Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.47 USD | -0.84% | +6.17% | +18.97% |
24/04 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
24/04 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
Business Summary
Number of employees: 76
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01/21/01 |
Director of Finance/CFO | 53 | 01/21/01 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 03/23/03 |
April Dovholuk
COO | Chief Operating Officer | - | 03/23/03 |
David Chao
ADM | Chief Administrative Officer | 56 | 01/21/01 |
Investor Relations Contact | - | 01/22/01 | |
Harris Rotman
LAW | General Counsel | - | 01/22/01 |
Patrick Yue
PRN | Corporate Officer/Principal | - | 01/23/01 |
Iqbal Hussain
LAW | General Counsel | 43 | 01/21/01 |
Karen Anderson
HRO | Human Resources Officer | 57 | 30/22/30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 23/21/23 | |
Chairman | 54 | 01/20/01 | |
Brett Zbar
BRD | Director/Board Member | 51 | 01/21/01 |
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01/21/01 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 23/21/23 |
Arjun Goyal
BRD | Director/Board Member | - | 01/21/01 |
Carol Stuckley
BRD | Director/Board Member | 68 | 17/21/17 |
Director/Board Member | 70 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 100,305,850 | 88,670,371 ( 88.40 %) | 0 | 88.40 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.97% | 1.05B | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CNTA Stock
- Company Centessa Pharmaceuticals plc